Healthcare & Life Sciences
Diagonal Therapeutics
United Statesdiagonaltx.com/
Diagonal Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Diagonal Therapeutics
Diagonal Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Diagonal Therapeutics develops multispecific clustering antibody therapeutics that target dysregulated cellular signaling pathways to treat and potentially modify the underlying causes of genetic and chronic diseases.
Explore Diagonal Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.